Metformin is one of the most widely prescribed medications in the world, and it comes up constantly in weight-loss conversations. Here is what it actually is, and is not, approved for.
An off-label use, stated plainly
Metformin is FDA-approved to manage blood sugar in adults, and in children over 10, with type 2 diabetes. It is not FDA-approved for weight loss. When a provider prescribes it specifically to help with weight, that is an off-label use: a legal and common practice in medicine, but a meaningfully different starting point from a medication like semaglutide or tirzepatide, which carry a direct FDA weight-management approval under specific brand names.
We state that plainly rather than glossing it, because the approval basis is exactly the kind of thing worth knowing before you decide what to ask your provider about.
How it works
Metformin acts on insulin sensitivity and on how much glucose the liver produces. That is a different mechanism from the GLP-1 receptor agonists, and it is why it is an older, separate class of medication rather than a cheaper version of one.
It is sometimes used on its own and sometimes alongside another medication, depending on what a provider determines is appropriate for a specific patient.
Who this is evaluated for
Miracle Leaf® does not make this determination. A licensed provider reviews your health history, current medications, and weight-related conditions, including whether you have prediabetes or type 2 diabetes, and decides whether metformin, alone or alongside another option, is appropriate for you.
For what a specific medication costs and whether it is available to you, ask the licensed provider who conducts your evaluation. Pricing depends on the product prescribed and on the pharmacy that fills it, so a figure quoted here would not reliably describe what you are offered.
How this compares to other options
Our semaglutide, oral semaglutide and tirzepatide pages cover the GLP-1 and dual-agonist options, including which branded products carry an FDA weight-management approval and which do not. Which of these is appropriate is a decision for the provider who evaluates you, based on your health history rather than on what you arrived intending to ask for.
Sources
- FDA-approved labeling for metformin hydrochloride, for the type 2 diabetes indication and the absence of a weight-management indication
- Public product description, Heally (getheally.com/patients/metformin), pulled 2026-07-23